Dr Sean Hood & Prof David Nutt

Dr Sean Hood MBBS MSc FRANZCP, senior lecturer in clinical psychopharmacology, School of Psychiatry & Clinical Neurosciences (M521), The University of Western Australia, Perth, Australia.

Dr Hood is psychiatrist in academic, public and private practice. He maintains a close working relationship with Prof Nutt's group in Bristol, UK. A main area of research interest is the neurobiology of anxiety and mood disorders. His recent research includes investigating neurotransmitter mechanisms in clinical anxiety disorders by pharmacological challenge.

Prof David Nutt, Head of the Department of Clinical Medicine and Dean of Clinical Medicine and Dentistry, based at the University of Bristol.

Prof Nutt received his undergraduate training in medicine at Cambridge and Guy's Hospital, and continued training in neurology to MRCP. After completing his psychiatric training in Oxford, he continued there as a lecturer and then later as a Wellcome Senior Fellow in psychiatry. He then spent two years as Chief of the Section of Clinical Science in the National Institute of Alcohol Abuse and Alcoholism in NIH, Bethesda, USA. On returning to England in 1988 he set up the Psychopharmacology Unit in Bristol, an interdisciplinary research grouping spanning the departments of Psychiatry and Pharmacology.

Prof Nutt is currently a member of the Advisory Council on the Misuse of Drugs, and Chair of its Technical Committee, as well as a member of the Committee on Safety of Medicines. In addition, he is advisor to the British National Formulary, the editor of the Journal of Psychopharmacology. He is President-elect of ECNP and the Past President of the British Association of Psychopharmacology.

Contributions to CNSforum by Dr Sean Hood & Prof David Nutt:

30.11.2007

Cognitive style, alprazolam plasma levels, and treatment response in panic disorder

31.10.2007

Dopamine Transporter Density in the Basal Ganglia in Obsessive-Compulsive Disorder, Measured with [123I]IPT SPECT before and after Treatment with Serotonin Reuptake Inhibitors

28.09.2007

Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: Reduction by a selective serotonin reuptake inhibitor

31.08.2007

Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents

31.07.2007

Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder

29.06.2007